Return to Contents in this Issue

Antihistamines in the treatment of chronic urticaria


I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 A del Cuvillo,6 J Mullol,7 J Sastre,8 A Valero5

1 Service of Allergy, Hospital de Basurto, Bilbao, Spain
2 Department of Allergology, Clínica Universitaria de Navarra, Pamplona, Spain
3 Allergy Unit, Hospital La Plana, Villarreal (Castellón), Spain
4 Service of Immunoallergy, Hospital Clínico, Salamanca, Spain
5 Allergy Unit, Service of Pneumology and Respiratory Allergy, Hospital Clínic (ICT), Barcelona, Spain
6 Clínica Dr. Lobatón, Cádiz, Spain
7 Rhinology Unit, ENT Service (ICEMEQ), Hospital Clínic, Barcelona, Spain
8 Service of Allergy, Fundación Jiménez Díaz, Madrid, Spain

J Investig Allergol Clin Immunol 2007; Vol. 17, Suppl. 2: 41-52



Chronic urticaria is highly prevalent in the general population, and while there are multiple treatments for the disorder, the results obtained are not completely satisfactory. The second-generation H1 antihistamines remain the symptomatic treatment option of choice. Depending on the different pharmacokinetics and H1 receptor affinity of each drug substance, different concentrations in skin can be expected, together
with different effi cacy in relation to the histamine-induced wheal inhibition test - though this does not necessarily have repercussions upon clinical response. The antiinflammatory properties of the H1 antihistamines could be of relevance in chronic urticaria, though it is not clear to what degree they infl uence the fi nal therapeutic result. Before moving on to another therapeutic level, the advisability of antihistamine dose escalation should be considered, involving increments even above those approved in the Summary of Product Characteristics. Physical urticaria, when manifesting isolatedly, tends to respond well to H1 antihistamines, with the exception of genuine solar urticaria and delayed pressure urticaria. In some cases of chronic urticaria, the combination of H2 antihistamines may prove effective - though only with common liver metabolism (CYP3A4 isoenzyme-mediated) H1 antihistamines, due to the existence of mutual metabolic interferences. The role of leukotriene antagonists associated to antihistamines in application to chronic urticaria remains to be clearly defined.

Key words: Angioedema. Cysteinyl-leukotriene antagonists. Antidepressants. H1 antihistamines. H2 antihistamines. Infl ammation. Histamine. Skin response to histamine. Skin. Chronic urticaria. Autoimmune chronic urticaria. Physical urticaria.